INTEGER HOLDINGS CORPORATION Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
INTEGER HOLDINGS CORPORATION (ITGR) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $125.00 thousand for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- INTEGER HOLDINGS CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-04-03 was $330.00K.
- INTEGER HOLDINGS CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-28 was -$519.00K, a 453.06% decline year-over-year.
- INTEGER HOLDINGS CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-29 was $147.00K, a 91.46% decline year-over-year.
- INTEGER HOLDINGS CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $1.72M, a 64.31% increase year-over-year.
- INTEGER HOLDINGS CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $1.64M.
- INTEGER HOLDINGS CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$243.00K, a 142.63% decline from fiscal 2023.
- INTEGER HOLDINGS CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $570.00K.
- INTEGER HOLDINGS CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$2.05M, a 299.90% decline from fiscal 2021.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-07-03 | $125.00K 10-Q · filed 2026-08-04 | |||
| 2026-04-03 | $330.00K 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | $1.64M 10-K · filed 2026-02-23 | |||
| 2025-09-26 | $1.65M 10-Q · filed 2025-10-23 | |||
| 2025-06-27 | $459.00K 10-Q · filed 2026-08-04 | |||
| 2025-03-28 | -$519.00K 10-Q · filed 2026-04-30 | |||
| 2024-12-31 | -$243.00K 10-K · filed 2026-02-23 | |||
| 2024-09-27 | -$668.00K 10-Q · filed 2025-10-23 | |||
| 2024-06-28 | $17.00K 10-Q · filed 2025-07-24 | |||
| 2024-03-29 | $147.00K 10-Q · filed 2025-04-24 | |||
| 2023-12-31 | $570.00K 10-K · filed 2026-02-23 | |||
| 2023-09-29 | $1.57M 10-Q · filed 2024-10-24 | |||
| 2023-06-30 | $1.78M 10-Q · filed 2024-07-25 | |||
| 2023-03-31 | $1.72M 10-Q · filed 2024-04-25 | |||
| 2022-12-31 | -$2.05M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | $209.00K 10-Q · filed 2023-10-26 | |||
| 2022-07-01 | -$6.25M 10-Q · filed 2023-07-27 | |||
| 2022-04-01 | $1.05M 10-Q · filed 2023-04-27 | |||
| 2021-12-31 | $1.02M 10-K · filed 2024-02-20 | |||
| 2021-10-01 | $553.00K 10-Q · filed 2022-10-27 | |||
| 2021-07-02 | $173.00K 10-Q · filed 2022-07-28 | |||
| 2021-04-02 | -$26.00K 10-Q · filed 2022-04-28 | |||
| 2020-12-31 | -$516.00K 10-K · filed 2023-02-21 | |||
| 2020-10-02 | -$597.00K 10-Q · filed 2021-10-28 | |||
| 2020-07-03 | -$236.00K 10-Q · filed 2021-07-29 | |||
| 2020-04-03 | -$243.00K 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | -$604.00K 10-K · filed 2022-02-22 | |||
| 2019-09-27 | -$13.00K 10-Q · filed 2020-10-29 | |||
| 2019-06-28 | $170.00K 10-Q · filed 2020-07-30 | |||
| 2019-03-29 | $382.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-28 | $2.58M 10-K · filed 2021-02-18 | |||
| 2017-12-29 | $2.23M 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |